ATP inhibits insulin-degrading enzyme activity

Area of Science:

• Biochemistry
• Enzymology

Background:

• Insulin-degrading enzyme (IDE) plays a crucial role in insulin metabolism.
• Understanding IDE regulation is vital for metabolic disease research.

Purpose of the Study:

• To investigate the inhibitory effect of Adenosine Triphosphate (ATP) on the degrading activity of insulin-degrading enzyme (IDE).
• To characterize the mechanism and kinetics of ATP-mediated inhibition of IDE.

Main Methods:

• Purification of IDE from rat skeletal muscle using chromatographic techniques.
• Enzyme characterization through insulin degradation assays, substrate competition, inhibitor profiling, and antibody recognition.
• Dose-dependent inhibition studies with varying ATP concentrations.
• Kinetic analysis including Lineweaver-Burk plots and Hill coefficient determination.
• Assessment of inhibition by various nucleotide analogs.

Main Results:

• Purified IDE exhibited characteristic enzymatic activity and inhibitor profiles.
• ATP demonstrated a dose-dependent inhibition of IDE's insulin degradation activity.
• Other nucleotides showed varying degrees of inhibition, generally less potent than ATP.
• Kinetic analysis indicated an allosteric mechanism of inhibition with a Hill coefficient > 1.
• The binding constant for allosteric inhibition (KiT) was determined to be 1.5 x 10(-7) M, signifying reduced enzyme affinity.

Conclusions:

• ATP significantly inhibits the in vitro insulin degradation activity of IDE.
• The inhibition mechanism appears to be allosteric, suggesting a regulatory role for ATP in IDE function.
• These findings provide insights into the biochemical regulation of IDE and its potential impact on insulin signaling pathways.